Month: April 2020

RAUTE OYJ SIJOITTAJAUUTINEN 29.4.2020 klo 15.15Rautessa on tänään päästy tuotannon työntekijöiden kanssa paikalliseen sopimukseen maksimissaan 80 tunnin työaikajoustojen käyttöön ottamisesta. Sopimus on voimassa vuoden. Lisäksi on sovittu siitä, että teknologiapalveluiden toimihenkilöitä voidaan siirtää tehtaalle töihin, kun huollon töitä ei matkustus- tai muiden koronaviruspandemian aiheuttamien rajoitusten takia voida tehdä.Samassa yhteydessä sovittiin, että edellä mainittujen sopimusten tullessa voimaan 22.8.2019 tiedotetut tuotannon työntekijöiden lomautukset päättyvät 30.4.2020. Lomautukset voidaan päättää, koska tilauskanta varmistaa tehtaan työllisyyden ainakin vuoden 2020 loppuun. Tilauskannan suuruudesta huolimatta mahdolliset komponenttien tai materiaalien saatavuusongelmat voivat aiheuttaa tarvetta sopeutuksille, mutta sellaisten...

RAUTE CORPORATION INVESTOR NEWS 29 April 2020 at 3:15 p.m.LOCAL AGREEMENT CONCLUDED AT RAUTE CONCERNING FLEXIBILITY OF WORKING HOURS – TEMPORARY LAYOFFS IN PRODUCTION TERMINATED Raute has today concluded a local agreement with the blue collar workers at the plant concerning implementation of at most 80 hours’ flexibility in working hours. The agreement is valid for one year.  Additionally has been agreed that white collar employees working in Technology services can be transferred to work in the production while the maintenance work cannot be done because of the travelling and other restrictions caused by the Covid -19 pandemic.It was also agreed that simultaneously with the above-mentioned agreements coming into force, the temporary layoffs in the production, announced on August 22, 2019, will be terminated on April 30, 2020. The good...

Date:   29 April 2020 

Southfield, Michigan, April 29, 2020 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE:SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates or has an interest in manufactured housing and recreational vehicle communities, today announced the pricing of an underwritten public offering of 4,320,000 shares of its common stock. The offering was upsized from 3,600,000 to 4,320,000 shares. As part of the offering, the Company granted the underwriters a 30-day option to purchase up to an additional 648,000 shares of its common stock. The offering is expected to close on Friday, May 1, 2020, subject to customary closing conditions.The Company intends to use the net proceeds of the offering to repay borrowings outstanding under the revolving loan under its senior credit facility, to fund possible future acquisitions...

These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an acceptable safety profile in Phase 2 studySystemic sclerosis is a rare autoimmune disease affecting ~200,000 people in the U.S., EU and Japan, and has the highest mortality rate among the systemic autoimmune diseasesPhase 3 study of lenabasum for the treatment of systemic sclerosis is on track for topline results in summer 2020Norwood, MA, April 29, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the publication of results from the double-blind, randomized, placebo-controlled Phase 2 trial assessing...

HOUSTON, April 29, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its first quarter 2020 earnings results before the NASDAQ Exchange opens Friday, May 8th, 2020. This release will be followed by an earnings call for investors on Monday, May 11, 2020, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) to discuss RigNet’s first quarter 2020 results. The call will be hosted by RigNet President and CEO, Steven Pickett.US and Canadian callers can access the call over the telephone by dialing +1 (877) 845-0777. For international callers, the number is +1 (760) 298-5090. Interested parties can also listen to a simultaneous webcast of the earnings call by logging onto RigNet’s website at www.rig.net in the Investors — Webcasts and Presentation section. A conference-call replay will...

REDWOOD CITY, Calif., April 29, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced the publication of an original scientific paper in Cancer Research, a journal of the American Association for Cancer Research, describing anti-tumor effects of a SHP2 inhibitor through modulation of key elements of the immune system in preclinical cancer models.  These findings demonstrate that inhibition of SHP2, a cellular protein that plays a central role in cell survival and growth, may exert therapeutic anti-tumor effects by modulating multiple arms of the immune response to the tumor in addition to reducing oncogenic signaling within tumor cells themselves.  Importantly, these data indicate that these...

EINDHOVEN, The Netherlands, April 29, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ:NXPI) (together with its subsidiaries, “NXP”) announced today that its subsidiaries NXP B.V., NXP Funding LLC and NXP USA, Inc. (together, the “Issuers”) intend to commence a private offering of senior unsecured notes (the “Notes”) pursuant to Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”).The Notes will be fully and unconditionally guaranteed on a senior basis by NXP Semiconductors N.V. and will be structurally subordinated to the liabilities, including trade payables, of NXP’s other subsidiaries. In addition, the Notes will be effectively junior to all future secured debt of the Issuers and NXP Semiconductors N.V., to the extent of the value of the assets securing such debt.NXP intends...